Janet Davis, MD
Ophthalmology · Miami, FLNPI 1316980923
Payments from drug & device makers
Across 17 payments — averaging $154.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Alcon$200
- Sun Pharmaceutical Industries Inc.$149
- Spark Therapeutics, Inc.$115
- ANI Pharmaceuticals, Inc.$25
- Mallinckrodt Enterprises LLC$24
- plus $20 from 1 others
What the payments were for
- Consulting fees$1,95074%
- Food & beverage$68526%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 9 | $2,102 |
| Alcon | 2 | $200 |
| Sun Pharmaceutical Industries Inc. | 1 | $149 |
| Spark Therapeutics, Inc. | 2 | $115 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Mallinckrodt Enterprises LLC | 1 | $24 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DRIZALMA SPRINKLE$149
- Clareon$148
How this compares
$2,635 in reported general payments places this provider in the 55th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 120 | $849,468 |
| Mycophenolate Mofetil | 79 | $17,530 |
| Difluprednate | 45 | $8,829 |
| Prednisolone Acetate | 223 | $8,597 |
| Valganciclovir Hcl | 13 | $5,433 |
| ValacyclovirValacyclovir Hcl | 38 | $4,473 |
| Ketorolac Tromethamine | 118 | $2,582 |
| MethotrexateMethotrexate Sodium | 104 | $1,961 |
| Azathioprine | 35 | $1,293 |
| Brimonidine Tartrate | 98 | $1,089 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 60 | $787 |
| Dexamethasone Sodium Phosphate | 12 | $646 |
| Dorzolamide Hcl | 31 | $589 |
| Latanoprost | 46 | $522 |
| Prednisone | 63 | $376 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Miami
- Guillermo AmescuaMiami$962K
- Felipe MedeirosMiami$935K
- Jennifer LohMiami$606K
- Jaclyn KovachMiami$590K
- William TrattlerMiami$580K
- Wilfredo LaraMiami$526K
- Jayanth SridharMiami$525K
- Kendall DonaldsonMiami$351K
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.